Jih-Luh Tang

6PUBLICATIONS
13CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

Sao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai

|Jan 22, 2024
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.

Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai

|Jan 04, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.

Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo

|Feb 25, 2022
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.

Wen-Li Hwang, Tsung-Chih Chen, Hsuan-Yu Lin

|Oct 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission.

Feng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang

|Oct 13, 2020
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden.

Yu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee

Pageof 1

Frequent Collaborators

5 joint publications

Feng-Ming Tien

5 joint publications

Wen-Chien Chou

5 joint publications

Hwei-Fang Tien

3 joint publications

Xavier Cheng-Hong Tsai